1. Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?. (24th November 2017) Authors: Figlin, R A; Leibovich, B C; Stewart, G D; Negrier, S Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 870PDEfficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). (23rd October 2018) Authors: Negrier, S; Rioux-Leclercq, N; Ravaud, A; Gravis, G; Geoffrois, L; Chevreau, C M; Rolland, F; Blanc, E; Segura-Ferlay, C; Perol, D; Gross Goupil, M; Dermeche, S; Flechon, A; Albiges, L; Escudier, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1306TiPILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma. (23rd October 2018) Authors: Ascierto, P A; Arenberger, P; Atkinson, V G; Hansson, J; Kapiteijn, E; Loquai, C; Negrier, S; Shaw, H M; Tarhini, A; Walker, J; Geib, J; Rahimian, S; Swann, S; Diab, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 878PTiNivo - tivozanib combined with nivolumab: Safety and efficacy in patients with metastatic renal cell carcinoma (mRCC). (23rd October 2018) Authors: Barthelemy, P; Escudier, B; Ravaud, A; Negrier, S; Needle, M N; Albiges, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 868PDBrain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial. (23rd October 2018) Authors: Flippot, R; Dalban, C; Laguerre, B; Borchiellini, D; Gravis, G; Negrier, S; Chevreau, C M; Joly, F; Geoffrois, L; Ladoire, S; Mahammedi, H; Tantot, F; Escudier, B; Albiges, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗